Stimulants 2021: Epidemiology, Effects and Treatments
Stimulants 2021: Epidemiology, Effects and Treatments
Course Description
US overdose deaths associated with stimulants (cocaine and methamphetamine) are now only exceeded by deaths associated with fentanyl. Because most cocaine and methamphetamine now being used in the US now contains fentanyl and because the methamphetamine currently being produced is more lethal than in past years, these drugs are extremely damaging to the body and brain. Individuals who use stimulants are challenging to engage and retain in treatment and they present unique clinical issues in treatment. There are no FDA-approved medications for treatment of stimulant use disorder, although several are promising. Behavioral treatment, especially using contingency management (and other approaches with supportive evidence), has by far the best evidence of effectiveness. This on-demand course will review these topic areas of importance to clinicians treating individuals with stimulant use disorder.
Launch Date: July 14, 2021
At the conclusion of the training, participants will be able to:
- Specify three (3) elements of the current epidemiology of cocaine and methamphetamine in the US.
- Identify three (3) common clinical challenges in the treatment of individuals with stimulant use disorder.
- Propose and discuss three (3) current evidence-based practices for the treatment of individuals with stimulant use disorder.
Instructions for Continuing Education Credits
How to receive a CE certificate:
You must pass the final test with a minimum of 80% correct. Once you pass the final test, you will be given links to complete a follow-up course evaluation. Choose the link that corresponds with the type of license you have. The link will take you to a course evaluation. Once you submit this required course evaluation, you will receive your CE certificate via email within six to eight weeks. Psychologists CE certificates will be physically mailed and can take up to six to eight weeks to arrive at your mailing address.
If you have any CE-related questions, please contact Darren Manley at dmanley@mednet.ucla.edu.
Continuing Education:
The training course meets the qualifications for the provision of two (2.0) continuing education credits/contact hours (CEs/CEHs). UCLA Integrated Substance Abuse Programs (ISAP) is approved by the American Psychological Association to sponsor continuing education for psychologists. UCLA ISAP maintains responsibility for this program and its content
UCLA ISAP is approved by the California Association of Marriage and Family Therapists to sponsor continuing education for LMFTs, LCSWs, LPCCs, and/or LEPs (Provider #64812). UCLA ISAP maintains responsibility for this program/course and its content. Course meets the qualifications for two (2.0) hours of continuing education credit for LMFTs, LCSWs, LPCCs, and LEPs as required by the California Board of Behavioral Sciences. UCLA ISAP is also an approved provider of continuing education for RADTs I/II, CADCs-CASs, CADCs I/II, CADCs-CSs, and LAADCs (CCAPP, #2N-21-339-1225), CATCs (ACCBC/CAADE, #CP40 872 C 0825), and CAODCs (CADTP, #151). CE credit will be awarded at the conclusion of the training. Partial credit will not be available for those participants who arrive late or leave early.
CE credit will be awarded at the conclusion of the training. Upon completing the final module, you must pass the final test with a minimum of 80% correct. Once you pass the final test, it will display a link to complete a course evaluation and submit the required information for your CE certificate. Upon completing this required course evaluation, you will receive your CE certificate via email within six to eight weeks.
If you have any CE-related questions, please contact Darren Manley at dmanley@mednet.ucla.edu.
Estimated time to complete the course:
Cost: Free
Disclosure statements:
Richard Rawson, PhD – Emeritus Professor
Trainer:
Richard Rawson, PhD
Department of Psychiatry and Biobehavioral Sciences, UCLA
Recommended Audience:
This online course is recommended for medical, behavioral health, and substance use disorder clinicians and administrative staff who are involved in providing multidisciplinary care to persons with opioid, stimulant, and other substance use disorders, including, but not limited to:
- Physicians
- Physician Assistants
- Nurse Practitioners
- Registered Nurses and LVNs
- Psychologists
- Marriage and Family Therapists
- Social Workers
- Alcohol and Other Drug and Mental Health Counselors
- Case Managers
- Medical Assistants
Instructions for Requesting Accommodations for Disability:
If you need a disability-related reasonable accommodation/alternative format for this event, please contact Darren Manley at dmanley@mednet.ucla.edu.
Instructions for Filing a Grievance Concerning UCLA ISAP’s Continuing Education Program:
Please contact Dr. Thomas E. Freese, CE Program Administrator, in writing:(UCLA ISAP, 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024) or by phone (310-267-5397). Alternately, you may contact Dr. Gloria Miele or Dr. James Peck, ISAP-affiliated doctoral-level psychologists responsible for program planning for the ISAP CE Program. Drs. Miele and Peck can be reached in writing at: 10911 Weyburn Ave, Suite 200, Los Angeles, CA 90024 or by phone at: 310-267-5888 (Miele) or 310-267-5346 (Peck).
